Indian scientists have developed a 'smart' cancer drug, RK-251, designed to specifically target tumour cells, potentially offering a more effective and less toxic alternative to traditional chemotherapy.
The drug works by identifying and attacking cancer cells while sparing healthy tissue, a breakthrough that could significantly improve the quality of life for patients undergoing treatment.
Clinical trials are expected to proceed following successful laboratory results, with the research team aiming to make this innovative therapy accessible and affordable for cancer patients across India.